Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, August 27, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
PerkinElmer Introduces Novel Research Tools at SLAS 2014
Monday, January 27, 2014
PerkinElmer Inc. introduced several novel products at SLAS2014, including the Opera® Phenix™ high content screening system, JANUS® chemagic nucleic acid workstation.

Fluxion Biosciences Releases IsoFlux Rare Cell Enrichment Kit
Tuesday, January 21, 2014
New bead chemistry enables more options for targeted cell enrichment.

Exiqon Launches Next Generation Sequencing Services
Tuesday, January 21, 2014
Services provide a complete sample-to-answer solution including biological interpretation of customer’s results.

Beckman Coulter Features Automated Solutions and Systems at SLAS2014
Monday, January 20, 2014
Workshops highlight meeting, while booth presentations add depth.

Illumina Introduces the HiSeq X™ Ten Sequencing System
Thursday, January 16, 2014
Breaks barriers with world's first $1,000 genome, enables 'factory' scale sequencing for population and disease studies.

Illumina Launches the NextSeq™ 500 Sequencing System
Thursday, January 16, 2014
Transformative addition to industry-leading portfolio brings whole genome sequencing to the desktop.

Massachusetts General Hospital Adopts Advanced Analytical Technology in Fight Against Cancer
Thursday, January 16, 2014
Company's Fragment Analyzer evaluates DNA and RNA of cancer patients.

New Improved Thermoelectrically Cooled MPPC for Photon Counting Applications
Tuesday, December 24, 2013
New S12576-050 and S12577-050 multi-pixel photon counter devices from Hamamatsu.

Agilent Introduces Two New ScreenTape Assays
Wednesday, December 18, 2013
Two new assays to optimize next-generation sequencing quality control, performance, throughput.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 200
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv